Advances of Mediastinal Lymph Node Metastasis and the Extent of Lymph Node Dissection in Patients with Stage T1 Non-small Cell Lung Cancer
10.3779/j.issn.1009-3419.2015.01.06
- VernacularTitle:T1期非小细胞肺癌纵隔淋巴结转移规律及清扫方式研究进展
- Author:
DING NINGNING
1
;
MAO YOUSHENG
Author Information
1. 北京协和医学院中国医学科学院肿瘤医院胸外科
- Keywords:
Lung neoplasms;
Lymph node metastasis;
Mediastinal lymph node dissection;
Mediastinal lymph node sampling
- From:
Chinese Journal of Lung Cancer
2015;(1):34-41
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer ranks the first position in morbidity and mortality among all malignances in China. Non-small cell lung cancer (NSCLC) accounts for nearly 80% of all lung malignancies. Surgical resection is still the current major treatment method for early stage NSCLC. Lymph node stages together with the extent of lymph node dissection directly afect the prognosis. Te site of primary lung carcinoma may afect the route and status of lymph node metastasis. Up to now, ana-tomical lobectomy and mediastinal lymph node dissection is deemed to be the standard surgical treatment for NSCLC. How-ever, it is still controversial in the extent of lymph node dissection for T1 NSCLC. More and more surgeons intend to perform selective mediastinal lymph node dissection instead of complete mediastinal lymph node dissection for T1 NSCLC in recent years.
